Background: As of 8 April 2021, a total of 2.9 million people have died with or from the
coronavirus infection causing COVID-19 (Corona Virus Disease 2019). On 29 January 2021 …

Globally, at the time of writing (20 March 2021), 121.759. 109 confirmed COVID-19 cases
have been reported to the WHO, including 2.690. 731 deaths. Globally, on 18 March 2021, a …

We report the case of a 50-year-old white man who had always been in good health. He was
a voluntary periodic blood donor (his last whole blood donation was on December 1, 2020) …

Importance Cases of cerebral venous sinus thrombosis in combination with
thrombocytopenia have recently been reported within 4 to 28 days of vaccination with the …

To date, billions of vaccine doses have been administered to restrain the current COVID-19
pandemic worldwide. Rare side effects, including intravascular blood clots, were reported in …

Background and purpose Cerebral venous sinus thrombosis (CVST) has been described
after vaccination against SARS‐CoV‐2. The clinical characteristics of 213 post‐vaccination …

Recent reports from the Centers of Disease Control and the US Food and Drug
Administration identified 6 cases of CVST associated with thrombocytopenia in US patients …

Recent reports have highlighted rare, and sometimes fatal, cases of cerebral venous sinus
thrombosis (CVST) and thrombocytopenia following the Vaxzevria vaccine. An underlying …

Objectives: Several cases of unusual thrombotic events with thrombocytopenia were
reported in several countries, in association with AstraZeneca's COVID-19 vaccine. The …

Background Development of vaccines with high efficacy against COVID-19 disease has
ushered a new ray of hope in the fight against the pandemic. Thromboembolic events have …